Liver Flashcards
Dosing ratio for ascites
Initial: 100 mg spironolactone + 40 mg furosemide
Max: 400 mg spironolactone + 160 mg furosemide
Titrate max q72 hours
Target: max 0.5 kg/day weight loss, up to 1 kg/day (edema)
Goals of HBV treatment
- Reduce morbidity & mortality
- Achieve immunologic cure (HBsAg loss with or without seroconversion, sustained HBV suppression)
- HBeAg seroconversion (if positive)
Monitoring for HBV treatment
Pre-treatment:
- Serologic test with HAV/HCV/HDV/HIV
- Hepatocellular carcinoma screening
- Fibrosis scanning using elastography
During treatment:
- Relevant side effects with antivirals
- HBV DNA titre
- LFT (esp AST/ALT)
- HBsAg (after undetectable DNA level reached)
- HBeAg and anti-HBe antibody (only after 12 months)
Cautions for anti-HBV drugs
- Entecavir (lactic acidosis)
- Tenofovir (nephropathy, lactic acidosis, osteomalacia)
- Lamivudine (pancreatitis, lactic acidosis, resistance)
- Peg-interferon 2a (blood dyscrasia, neuropsychiatric side effects, thyroiditis, cirrhosis decompensation)
Doses for anti-HBV drugs
Entecavir 0.5 mg OD
Tenofovir 300 mg OD
Peg-interferon alpha 2a 180 mg SC once weekly
Beta blockers for variceal prophylaxis
Carvedilol 6.25 mg BD
Propanolol 20-40 mg BD
Nadolol 20-40 mg OD
Add on EVL q1-4 weeks if for secondary prophylaxis
Primary prophylaxis for variceal bleeding
EVL q2-8 weeks OR
BBs
- Propranolol up to 160 mg per day in 2 divided doses
- Carvedilol up to 12.5 mg per day in 2 divided doses
- Nadolol up to 80 mg once a day
Management of SBP
- PMN > 250 mm3 in ascitic fluids
- Bacteria: Gram -ve (E. coli, K. pneumoniae) and Gram +ve (S. aureus, E. faecalis, E. faecium)
- DOC: IV Ceftriaxone 1 g/day for 7 days
- Nosocomial concerns: IV Meropenem, Vancomycin
- IV Albumin 25% solution: 1.5 g/kg on day 1, 1 g/kg on day 3
Treatment of hepatic encephalopathy
- PO Lactulose 30-45 mL q1-2 hours until catharsis reached
- Titrated to maintenance amount (2-3 loose stools/day)
- PO Rifaximin 550 mg BD for prevention of recurrent HE